At Kamal Medtech, our greatest asset is our dedicated and skilled workforce.
We pride ourselves on fostering a culture of innovation, collaboration, and
excellence. Our team is composed of highly trained professionals who bring
together a wealth of expertise in engineering, design, research, and healthcare.
The medical devices industry, its potential and applications are an expanding and dynamic domain. Multiple stakeholders have expectations from this industry which is seized with not only making life better, but also preserving it. These rising expectations from our communities, investors, governments and customers only underscore the critical importance of work underway throughout Kamal Medtech. We have to ensure that we remain well positioned in meeting these expectations. As we continue to create a refreshingly new company on bold new ideas, we do it with ingenuity, creativity, sensitivity and courage. Our people are innovators who embody these traits.
Our team of visionary leaders and skilled
professionals are the driving force behind Kamal
Medtech’s success. Together, they work relentlessly
to innovate and create medical solutions that
transform healthcare worldwide.
Founder & CEO
Entrepreneur and business leader, Vikram Pratap is Founder and CEO of Kamal Medtech. He also serves on the board of Kamal Encon Industries. Earlier tenures include leadership positions at KEC Industries, Investment Banking at EVE Partners, Atlanta, US (offshoot of Credit Suisse First Boston) and Cap Gemini (Erstwhile Ernst & Young Consulting, Atlanta, US).
Widely acknowledged for developing, prototyping & successfully commercializing several new technologies at Kamal Encon focused on Waste Heat Recovery Units, Boilers, Heaters, etc. for Oil Refineries, PetroChemical & Fertilizer Plants and creating a global client base, Vikram has been instrumental in creating world-class ecosystems. The latest creation is a MedTech park which houses Govt. of India DSIR recognized R&D centre, latest state of the art precision manufacturing facilities producing highest quality oriented medical devices which are all CE Marked from European notified bodies, addressing dental implantology and interventional cardiology where Vikram has played a key role in driving IPR creation in India for internationally benchmarked medical devices. Kamal Medtech manufactures gold standard international medical devices in India and supplies to markets globally.
Vikram holds a Bachelor of Commerce (Honors) from the Hindu College, University of Delhi; a Masters in Supply Chain & Operations from University of Wales, Cardiff and an MBA from Emory University’s Goizueta Business School, Atlanta, US.
Chief Technology Officer
An engineer with proven expertise in the design and development of drug eluting stents distinguished by their uniqueness in terms of design, adaptability, application and agility, Mr. Abhishek Masalawala leads the mandate for interventional cardiology at Kamal Medtech. In a distinguished career he has held head of function positions with leading industry names: Sahajanand Medical Technologies Pvt Ltd, N.S Remedies Pvt Ltd, MIV Therapeutics (India) Pvt Ltd. among others. Mr. Masalawala has created incremental value in each role through organizational competency building, optimal quality standardization and efficiencies of scale. Subsequent appointments have been with Nano Therapeutics Pvt. Ltd. where he led the comprehensive manufacturing function, and operations besides R&D for interventional cardiology. He subsequently moved to Vietnam in a senior leadership role at USM Healthcare. For the Vietnam market he developed and launched drug eluting coronary stent systems and PTCA dilatation catheters.
Mr. Abhishek Masalawala’s core expertise lies in research, design, development and production of interventional cardiology devices, with cross sectional expertise in the entire category of drug eluting coronary stents. Development of niche devices with unique agility and adaptability based on biomimicry, Abhishek Masalawala engineers a variety of interventional cardiology solutions. Mr. Masalawala holds a bachelor’s degree in Chemical Engineering from the Dharmsinh Desai Institute of Technology, Nadiad.
Member of the Board
Cross functional multi-industry leader, active angel investor and advisory board member, Rajiv Kapahi has more than three decades of cross-functional, diverse industry experience in senior leadership roles. With a demonstrated record of consistent success in creating optimal performance metrics at the board level and as a CXO/CFO, he is well known across corporate and regulatory circles. Rajiv’s rich corporate experience across management consulting, office automation, manufacturing, healthcare, IT/ITES, life insurance and medical devices industries for Indian and international organizations, is demonstrated by enduring value creation and impact. His expertise extends to initiating and advising family offices, facilitating set-up and/or scaling of VC and PE firms, angel networks and industry bodies. This is complemented by expertise in enabling cross-border investments and global alliances. Across a long and decorated career, Rajiv Kapahi has established several Indian entities as subsidiaries, joint ventures, start-ups. And is acknowledged for business turn-arounds of multinational and Indian corporates.
Entrepreneur at heart, Rajiv has been continually generating, co-creating and leveraging value for various start-ups across domains. These range from Artificial Intelligence to Healthtech, to Digital & New Age Media. A highlight is his current focus on architecting a pioneering and unique enterprise driven by purpose of creating and scaling high impact technology solutions focused on environmental sustainability, energy generation, waste management. Once realized these, will be supplemented by security, healthcare, agri-tech, advanced manufacturing, et al.
Trustee and member of the CFO Board (India), and elected member of NATHEALTH (apex forum of Indian healthcare organizations), Rajiv Kapahi is a Chartered Accountant by training.
Member of the Board
Engineer and technocrat, Adarsh Soni has held diverse briefs over an illustrious and extended career of more than five decades. From petrochemicals to heavy engineering to precision medical equipment, Mr. Soni has a uniquely rich perspective gained across varied roles, different geographies and positions at the helm of technology led businesses. He has served tenure with almost all major licensing and engineering companies in the refining and petrochemical sector {UOP, Axens, Exxon Mobil, Bechtel, Flour Daniel, Toyo, and Technip, among others}. At present, in addition to position on the Board, Mr. Soni’s oversight extends to design and development, process standardization, production, QC/QA, and regulatory compliances for dental implants and prosthetics, besides drug eluting coronary stent systems at Kamal Medtech. In parallel, he serves Kamal Encon Industries Limited (medical division) as president. He also chairs Industrial Development Services Pvt. Ltd. Earlier tenure includes Punj Lloyd Ltd., MRPL/ONGC, Engineers India Ltd. (EIL). Mr. Soni commenced his career with Larsen & Toubro (L&T).
A keen advocate of currency of knowledge and constant learning, Mr. Adarsh Soni’s technical professional training includes international residential programmes with Lummus, Foster Wheeler, Norton, Oschatz, Koerting, Aker Engineering. He also attended the Advanced Management Programme for Public Enterprise Executives at the Administrative Staff College of India, Hyderabad. Mr. Soni’s professional certifications and membership of peer reviewed professional associations include life membership of the Indian Institute of Chemical Engineers He has also been a member of the Scientific Advisory Committee of the Ministry of Petroleum and Natural Gas, Government of India. Mr. Adarsh Soni was felicitated with the Lifetime Achievement Award by the Indian Institute of Chemical Engineers, the Award for Excellence for Creativity and Innovation (Team Category) by the Ministry of Petroleum and Natural Gas, Government of India.
Mr. Adarsh Soni holds a B.Tech. in Chemical Engineering from the Indian Institute of Technology (IIT), Delhi and an MBA from the Faculty of Management Studies (FMS), University of Delhi.
Head-Training & Marketing
Dr. Neeta Shetty heads training, learning and development besides marketing, for the dental implants and prosthetics business at Kamal Medtech . With end-to-end responsibility for operations, developing market activation and sales, R&D as well as industry-academia partnerships, Dr. Shetty is a key member of the leadership team. An industry veteran, her previous tenure includes appointments with Dio Digital Implants, Novabone India, Dentsply Sirona, Nobel Biocare.
Dr. Neeta Shetty holds a BDS from the SDM College, Dharwad. She trained at the Nobel Biocare APAC Headquaters on CAD/CAM. Neeta was conferred the peer reviewed Best Practices Award (Individual Contributor) twice consecutively, by Nobel Biocare and acknowledged separately with the Outstanding Achievement in Marketing, Training & Education Award by the same institution.
Country Manager India & Head-Export Markets
A healthcare marketing professional, Mr. Mohammad Qadry’s expertise lies in a unique mix of management, pharmaceuticals and medical devices. With a focus on optimizing business potentials, creating value across business ecosystems and a uniquely embedded customer focus, Mr. Qadry has developed several markets. Mohammad Qadry’s previous appointments include leadership positions with Dio Digital Implants, B Braun India, Nobel Biocare.
He holds a Post Graduate Diploma in Business Administration from IPM, Ghaziabad with specialization in Market Research. This was preceded by a Diploma in Pharmacy from Jamia Hamdard University and a bachelor’s degree in Science with majors in Zoology, Botany and Chemistry from the University of Delhi.
President, Global Business and R&D
With extensive experience and deep understanding of interventional cardiology across categories, complemented by deep understanding in business development and R&D, Neel Arvind has served tenure in various organizations globally. These include Bley, and QMed Germany; AMG India (a subsidiary of AMG International GmbH, Germany); MIV Therapeutic Inc. Canada, Schering Plough Corporation, USA – in leadership positions with comprehensive functional, administrative and business responsibility. These organizations represent almost the entire spectrum of interventional cardiology in medical devices, globally.
Neel Arvind holds a master’s degree in Science and an MBA.
Advisor: Public Affairs
Amit Chaudhery has worked at the intersection of Corporate Reputation Management, Business Communications, Media and Public Diplomacy for an extended period of time. Across multiple sectors and categories, in senior leadership briefs, his tenure includes marquee brands in healthcare {Smile Train Inc., Medanta, Max Healthcare}, building materials, refractories, sugar {Dalmia Bharat Group, Craft Beton}, management consulting {Next Fifteen/Text100 Plc.} telecom and consumer tech {Motorola Inc.}, financial services {Max New York Life Insurance}, speciality plastics and packaging {Max Group},direct selling {Amway Inc.}, tobacco {ITC Limited, The Tobacco Institute of India}, social enterprise and culture {International Delphic Council, Berlin}. As a broadcast journalist, writer, researcher {Los Angeles Times, Voice of America, NDTV, Observer Channel, Business India TV}. A peer reviewed and academically referenced writer with 25 peer reviewed mentions content his work is housed in international universities and think tanks and the US Library of Congress, besides literary festivals at Syracuse University. With 80 television credits, nine books, more than 50 peer reviewed articles, Amit Chaudhery is also a certified independent director at the Institute of Directors India and a representative neutral with the Federation of Integrated Conflict Management. In parallel, Amit Chaudhery represented independent opinion as a Government of India nominated expert (CPCSEA) on several institutional ethics committees: the Defence Research & Development Organization (DRDO), Defence Institute of Physiology, Indian Council of Agricultural Research (ICAR) Indira Gandhi National Open University and the Maulana Azad Medical College.
Honours include ‘100 Most Impactful CSR Leaders (Global Ranking) the World CSR Congress; citation by Ashoka University and Singularity University NASA campus (Global Impact Competition); Public Relations Society of India Leadership Award – Brand Guru; Gold Award, Association of Business Communicators of India; Sanctuary – ABM AMRO Natural History Writer Award; the UNESCO-PEN shortlist; Indira Super Achievers Award. In 2015 Chaudhery was co-opted as an honorary member by the Bishnoi community (Akhil Bhartiya Jeev Raksha Bishnoi Sabha) for his interventions in wildlife conservation.
Amit Chaudhery was educated at Modern School, New Delhi, read History at St. Stephen’s College, University of Delhi, holds a master’s degree in public administration from the Punjab University, Chandigarh, and a diploma in Journalism from the London School, of Journalism. Chaudhery was awarded a doctorate in Advanced Studies by the Universidad Azteca, Mexico. He undertook an executive education course by the founding professor, in Reputation Management at the Stern School of Business, New York University. He is a member of the Reputation Institute, USA
Yes, we provide proper training and support for every medical device purchased from Kamal Medtech. Our experts take sessions to ensure the effective use of our products across both Interventional Cardiology and Dental Implantology.
Yes, we have a global presence in over 70 countries. Our world-class medical devices reflect our commitment to providing the best and safest medical solutions worldwide.
Yes, at Kamal, we have a vast manufacturing facility of 30,000 sq. feet where we manufacture Indigenous Products. These high-quality medical devices are trusted and exported to markets around the world.
Yes, Kamal is a certified manufacturer with ISO 13485:2016 certification, as well as CE Marks for the Everolimus Eluting Coronary Stent System and the Sirolimus-Eluting Coronary Stent System.
We have served over 9,000 customers globally with our best-in-class medical devices.